These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23337034)

  • 1. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients.
    Palomino A; González-Pinto A; Martinez-Cengotitabengoa M; Ruiz de Azua S; Alberich S; Mosquera F; Matute C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():29-33. PubMed ID: 23337034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
    Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder.
    Palomino A; González-Pinto A; Aldama A; González-Gómez C; Mosquera F; González-García G; Matute C
    Schizophr Res; 2007 Sep; 95(1-3):174-8. PubMed ID: 17630258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the experience of caregiving in bipolar affective disorder and schizophrenia.
    Grover S; Chakrabarti S; Aggarwal M; Avasthi A; Kulhara P; Sharma S; Khehra N
    Int J Soc Psychiatry; 2012 Nov; 58(6):614-22. PubMed ID: 21873293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
    Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.
    Bombin I; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; de la Serna E; Rapado-Castro M; Barbeito S; Parellada M; Baeza I; Graell M; Payá B; Arango C
    Psychol Med; 2013 Apr; 43(4):757-68. PubMed ID: 22831788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
    Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder.
    Dickerson F; Stallings C; Origoni A; Boronow J; Yolken R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):952-5. PubMed ID: 17391822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
    Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode.
    Machado-Vieira R; Dietrich MO; Leke R; Cereser VH; Zanatto V; Kapczinski F; Souza DO; Portela LV; Gentil V
    Biol Psychiatry; 2007 Jan; 61(2):142-4. PubMed ID: 16893527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Naveen MN; Thirthall J; Gangadhar BN; Shetty KT
    Am J Psychiatry; 2007 Oct; 164(10):1557-60. PubMed ID: 17898347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of GDNF in bipolar disorder.
    Barbosa IG; Huguet RB; Sousa LP; Abreu MN; Rocha NP; Bauer ME; Carvalho LA; Teixeira AL
    Neurosci Lett; 2011 Sep; 502(2):103-6. PubMed ID: 21820487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
    Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
    Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine serum level in schizophrenia: relation to negative symptoms.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Doubek P; Libiger J
    Psychiatry Res; 2010 Apr; 176(2-3):103-8. PubMed ID: 20096465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.